Altered serotonergic function may partially account for behavioral endophenotypes in steroid sulfatase-deficient mice

Neuropsychopharmacology

Volumn 37, Issue 5, 2012, Pages 1267-1274

  Trent, Simon ^a   Cassano, Tommaso ^b   Bedse, Gaurav ^c   Ojarikre, Obah A ^d   Humby, Trevor ^a   Davies, William ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF FOGGIA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

attention deficit hyperactivity disorder; dehydroepiandrosterone sulfate; hippocampus; obsessive?compulsive disorder; progressive ratio; striatum

Indexed keywords

MONOAMINE; SEROTONIN; STERYL SULFATASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR GENETICS; BRAIN TISSUE; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; ENDOPHENOTYPE; FRONTAL CORTEX; GENE; GENE MUTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; INFORMATION PROCESSING; LOCOMOTION; MALE; MOTIVATION; MOUSE; NERVE FUNCTION; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; STS GENE; TASK PERFORMANCE; THALAMUS; THINKING; WILD TYPE;

ACOUSTIC STIMULATION; AGE FACTORS; ANIMALS; BIOGENIC MONOAMINES; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; ENDOPHENOTYPES; EXPLORATORY BEHAVIOR; ICHTHYOSIS, X-LINKED; MICE; REINFORCEMENT (PSYCHOLOGY); SEROTONIN; STATISTICS, NONPARAMETRIC; STERYL-SULFATASE;

EID: 84858339654     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.314     Document Type: Article

References (49)

1. Adhikari A, Topiwala MA, Gordon JA (2011). Synchronized activity between the ventral hippocampus and the medial prefrontal cortex during anxiety. Neuron 65: 257-269.
2. Albelda N, Joel D (2011). Animal models of obsessive-compulsive disorder: Exploring pharmacology and neural substrates. Neurosci Biobehav Rev 36: 47-63.
3. Avale ME, Nemirovsky SI, Raisman-Vozari R, Rubinstein M (2004). Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine. J Neurosci Res 78: 289-296.
4. Brookes KJ, Hawi Z, Kirley A, Barry E, Gill M, Kent L (2008). Association of the steroid sulfatase (STS) gene with attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147B: 1531-1535.
5. Brookes KJ, Hawi Z, Park J, Scott S, Gill M, Kent L (2010). Polymorphisms of the steroid sulfatase (STS) gene are associated with attention deficit hyperactivity disorder and influence brain tissue mRNA expression. Am J Med Genet B Neuropsychiatr Genet 153B: 1417-1424.
6. Carlson CL, Booth JE, Shin M, Canu WH (2002). Parent-, teacher-, and self-rated motivational styles in ADHD subtypes. J Learn Disabil 35: 104-113.
7. Carola V, Frazzetto G, Pascucci T, Audero E, Puglisi-Allegra S, Cabib S et al (2008). Identifying molecular substrates in a mouse model of the serotonin transporter x environment risk factor for anxiety and depression. Biol Psychiatry 63: 840-846.
8. Cassano T, Gaetani S, Morgese MG, Macheda T, Laconca L, Dipasquale P et al (2009). Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion. Neurochem Res 34: 1417-1426.
9. Chelonis JJ, Gravelin CR, Paule MG (2011a). Assessing motivation in children using a progressive ratio task. Behav Processes 87: 203-209.
10. Chelonis JJ, Johnson TA, Ferguson SA, Berry KJ, Kubacak B, Edwards MC et al (2011b). Effect of methylphenidate on motivation in children with attention-deficit/hyperactivity disorder. Exp Clin Psychopharmacol 19: 145-153.
11. Chen K, Cases O, Rebrin I, Wu W, Gallaher TK, Seif I et al (2007). Forebrain-specific expression of monoamine oxidase A reduces neurotransmitter levels, restores the brain structure, and rescues aggressive behavior in monoamine oxidase A-deficient mice. J Biol Chem 282: 115-123.
12. Compagnone NA, Salido E, Shapiro LJ, Mellon SH (1997). Expression of steroid sulfatase during embryogenesis. Endocrinology 138: 4768-4773.
13. Cormier E (2008). Attention deficit/hyperactivity disorder: A review and update. J Pediatr Nurs 23: 345-357.
14. Davies W, Humby T, Kong W, Otter T, Burgoyne PS, Wilkinson LS (2009). Converging pharmacological and genetic evidence indicates a role for steroid sulfatase in attention. Biol Psychiatry 66: 360-367.
15. Doe CM, Relkovic D, Garfield AS, Dalley JW, Theobald DE, Humby T et al (2009). Loss of the imprinted snoRNA mbii-52 leads to increased 5htr2c pre-RNA editing and altered 5HT2CR-mediated behaviour. Hum Mol Genet 18: 2140-2148.
16. Doherty MJ, Glass IA, Bennett CL, Cotter PD, Watson NF, Mitchell AL et al (2003). An Xp; Yq translocation causing a novel contiguous gene syndrome in brothers with generalized epilepsy, ichthyosis, and attention deficits. Epilepsia 44: 1529-1535.
17. Durston S (2008). Converging methods in studying attentiondeficit/ hyperactivity disorder: What can we learn from neuroimaging and genetics? Dev Psychopathol 20: 1133-1143.
18. Eagle DM, Baunez C (2010). Is there an inhibitory-responsecontrol system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci Biobehav Rev 34: 50-72.
19. Fletcher PJ, Sinyard J, Higgins GA (2010). Genetic and pharmacological evidence that 5-HT2C receptor activation, but not inhibition, affects motivation to feed under a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav 97: 170-178.
20. Geller DA (2006). Obsessive-compulsive and spectrum disorders in children and adolescents. Psychiatr Clin North Am 29: 353-370.
21. Gourley SL, Lee AS, Howell JL, Pittenger C, Taylor JR (2010). Dissociable regulation of instrumental action within mouse prefrontal cortex. Eur J Neurosci 32: 1726-1734.
22. Harrison AA, Everitt BJ, Robbins T W (1997). Doubly dissociable effects of median- and dorsal-raphe lesions on the performance of the five-choice serial reaction time test of attention in rats. Behav Brain Res 89: 135-149.
23. Humby T, Laird FM, Davies W, Wilkinson LS (1999). Visuospatial attentional functioning in mice: Interactions between cholinergic manipulations and genotype. Eur J Neurosci 11: 2813-2823.
24. Kent L, Emerton J, Bhadravathi V, Weisblatt E, Pasco G, Willatt LR et al (2008). X-linked ichthyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits. J Med Genet 45: 519-524.
25. Lonardo F, Parenti G, Luquetti DV, Annunziata I, Della Monica M, Perone L et al (2007). Contiguous gene syndrome due to an interstitial deletion in Xp22.3 in a boy with ichthyosis, chondrodysplasia punctata, mental retardation and ADHD. Eur J Med Genet 50: 301-308.
26. Milunsky J, Huang XL, Wyandt HE, Milunsky A (1999). Schizophrenia susceptibility gene locus at Xp22.3. Clin Genet 55: 455-460.
27. Nelson RJ, Trainor BC (2007). Neural mechanisms of aggression. Nat Rev Neurosci 8: 536-546.
28. Oades RD (2007). Role of the serotonin system in ADHD: Treatment implications. Expert Rev Neurother 7: 1357-1374.
29. Odorisio T, Rodriguez TA, Evans EP, Clarke AR, Burgoyne PS (1998). The meiotic checkpoint monitoring synapsis eliminates spermatocytes via p53-independent apoptosis. Nat Genet 18: 257-261.
30. Perez-Neri I, Mendez-Sanchez I, Montes S, Rios C (2008). Acute dehydroepiandrosterone treatment exerts different effects on dopamine and serotonin turnover ratios in the rat corpus striatum and nucleus accumbens. Prog Neuropsychopharmacol Biol Psychiatry 32: 1584-1589.
31. Popova NK (2006). From genes to aggressive behavior: The role of serotonergic system. Bioessays 28: 495-503.
32. Reddy DS (2010). Neurosteroids: Endogenous role in the human brain and therapeutic potentials. Prog Brain Res 186: 113-137.
33. Reed MJ, Purohit A, Woo LW, Newman SP, Potter BV (2005). Steroid sulfatase: Molecular biology, regulation, and inhibition. Endocr Rev 26: 171-202.
34. Rhodes ME, Li PK, Burke AM, Johnson DA (1997). Enhanced plasma DHEAS, brain acetylcholine and memory mediated by steroid sulfatase inhibition. Brain Res 773: 28-32.
35. Roane HS (2008). On the applied use of progressive-ratio schedules of reinforcement. J Appl Behav Anal 41: 155-161.
36. Robbins TW (2002). The 5-choice serial reaction time task: Behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163: 362-380.
37. Robbins TW, Arnsten AF (2009). The neuropsychopharmacology of fronto-executive function: Monoaminergic modulation. Annu Rev Neurosci 32: 267-287.
38. Rowles BM, Findling RL (2010). Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders. Dev Disabil Res Rev 16: 273-282.
39. Sanders AC, Hussain AJ, Hen R, Zhuang X (2007). Chronic blockade or constitutive deletion of the serotonin transporter reduces operant responding for food reward. Neuropsychopharmacology 32: 2321-2329.
40. Shinomiya K, Fujii Y, Sugimoto Y, Azuma N, Tokunaga S, Kitazumi K et al (2005). Effect of paroxetine on marbleburying behavior in mice. Methods Find Exp Clin Pharmacol 27: 685-687.
41. Singh VB, Kalimi M, Phan TH, Boadle-Biber MC (1994). Intracranial dehydroepiandrosterone blocks the activation of tryptophan hydroxylase in response to acute sound stress. Mol Cell Neurosci 5: 176-181.
42. Sodhi MS, Sanders-Bush E (2004). Serotonin and brain development. Int Rev Neurobiol 59: 111-174.
43. Stergiakouli E, Langley K, Williams H, Walters J, Williams NM, Suren S et al (2011). Steroid sulfatase is a potential modifier of cognition in attention deficit hyperactivity disorder. Genes Brain Behav 10: 334-344.
44. Thomas NS, Sharp AJ, Browne CE, Skuse D, Hardie C, Dennis NR (1999). Xp deletions associated with autism in three females. Hum Genet 104: 43-48.
45. Tobias ES, Bryce G, Farmer G, Barton J, Colgan J, Morrison N et al (2001). Absence of learning difficulties in a hyperactive boy with a terminal Xp deletion encompassing the MRX49 locus. J Med Genet 38: 466-470.
46. Trent S, Dennehy A, Richardson H, Ojarikre OA, Burgoyne PS, Humby T et al (2011). Steroid sulfatase-deficient mice exhibit endophenotypes relevant to attention deficit hyperactivity disorder. Psychoneuroendocrinology; e-pub ahead of print 30 June 2011; doi:10.1016/j.psyneuen.2011.06.006.
47. Umathe SN, Vaghasiya JM, Jain NS, Dixit PV (2009). Neurosteroids modulate compulsive and persistent behavior in rodents: Implications for obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 33: 1161-1166.
48. Webster RA (2001). Neurotransmitters, drugs and brain function. Wiley.
49. Wilens TE, Spencer TJ (2010). Understanding attention-deficit/ hyperactivity disorder from childhood to adulthood. Postgrad Med 122: 97-109.